Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 3
2004 1
2005 1
2007 4
2009 1
2010 3
2011 4
2012 4
2014 1
2015 2
2016 1
2017 1
2018 1
2019 1
2022 1
2023 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes from treatment of metastatic renal-cell carcinoma following failure of first-line anti-VEGF/VEGFR therapy: real-life evidence on the change of the treatment paradigm.
Bamias A, Zakopoulou R, Tzannis K, Sakellakis M, Koutsoukos K, Kyriazoglou A, Panagiotou A, Armylagos S, Rokas K, Gotzias D, Boulouta A, Bozionelou V, Stravodimos K, Varkarakis I, Mavroudis D, Dimopoulos MA. Bamias A, et al. Among authors: bozionelou v. Anticancer Drugs. 2023 Mar 1;34(3):413-421. doi: 10.1097/CAD.0000000000001420. Epub 2022 Nov 16. Anticancer Drugs. 2023. PMID: 36730619 Clinical Trial.
Dedifferentiated paratesticular liposarcoma with osseous metaplasia.
Chondros K, Heretis I, Papadakis M, Bozionelou V, Mavromanolakis E, Chondros N, Mamoulakis C. Chondros K, et al. Among authors: bozionelou v. Case Rep Urol. 2015;2015:965876. doi: 10.1155/2015/965876. Epub 2015 Apr 16. Case Rep Urol. 2015. PMID: 25960913 Free PMC article.
Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group.
Pallis AG, Karampeazis A, Vamvakas L, Vardakis N, Kotsakis A, Bozionelou V, Kalykaki A, Hatzidaki D, Mavroudis D, Georgoulias V. Pallis AG, et al. Among authors: bozionelou v. Ann Oncol. 2011 Nov;22(11):2448-2455. doi: 10.1093/annonc/mdq772. Epub 2011 Mar 10. Ann Oncol. 2011. PMID: 21393380 Free article.
Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece--the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG).
Tsironis G, Koutsoukos K, Athanasakis K, Tsiara A, Tzannis K, Gerolympou M, Visvikis A, Oikonomopoulos G, Kollia A, Giannopoulou E, Dimitra M, Kostouros E, Papatsoris A, Dellis A, Stravodimos K, Varkarakis I, Samantas E, Aravantinos G, Kentepozidis N, Christodoulou C, Bozionelou V, Dimopoulos MA, Bamias A. Tsironis G, et al. Among authors: bozionelou v. Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):491-501. doi: 10.1080/14737167.2019.1546121. Epub 2018 Nov 19. Expert Rev Pharmacoecon Outcomes Res. 2019. PMID: 30417707
Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study.
Georgoulias V, Bozionelou V, Agelaki S, Perraki M, Apostolaki S, Kallergi G, Kalbakis K, Xyrafas A, Mavroudis D. Georgoulias V, et al. Among authors: bozionelou v. Ann Oncol. 2012 Jul;23(7):1744-50. doi: 10.1093/annonc/mds020. Epub 2012 Feb 29. Ann Oncol. 2012. PMID: 22377561 Free article. Clinical Trial.
Utilization of Systemic Chemotherapy in Advanced Urothelial Cancer: A Retrospective Collaborative Study by the Hellenic Genitourinary Cancer Group (HGUCG).
Bamias A, Peroukidis S, Stamatopoulou S, Tzannis K, Koutsoukos K, Andreadis C, Bozionelou V, Pistalmatzian N, Papatsoris A, Stravodimos K, Varthalitis I, Karamouzis M, Milaki G, Agorastos A, Kentepozidis N, Androulakis N, Bompolaki I, Kalofonos H, Mavroudis D, Dimopoulos MA. Bamias A, et al. Among authors: bozionelou v. Clin Genitourin Cancer. 2016 Apr;14(2):e153-9. doi: 10.1016/j.clgc.2015.09.009. Epub 2015 Sep 25. Clin Genitourin Cancer. 2016. PMID: 26437909
A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.
Karachaliou N, Ziras N, Syrigos K, Tryfonidis K, Papadimitraki E, Kontopodis E, Bozionelou V, Kalykaki A, Georgoulias V, Mavroudis D. Karachaliou N, et al. Among authors: bozionelou v. Cancer Chemother Pharmacol. 2012 Jul;70(1):169-76. doi: 10.1007/s00280-012-1901-3. Epub 2012 Jun 6. Cancer Chemother Pharmacol. 2012. PMID: 22669571 Clinical Trial.
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program.
Pallis AG, Mavroudis D, Androulakis N, Souglakos J, Kouroussis C, Bozionelou V, Vlachonikolis IG, Georgoulias V. Pallis AG, et al. Among authors: bozionelou v. Lung Cancer. 2003 Jun;40(3):301-7. doi: 10.1016/s0169-5002(03)00079-5. Lung Cancer. 2003. PMID: 12781429 Clinical Trial.
26 results